Tandem Diabetes Care Inc (FRA:TD5A)
€ 46.5 -0.61 (-1.29%) Market Cap: 3.09 Bil Enterprise Value: 3.10 Bil PE Ratio: 0 PB Ratio: 13.74 GF Score: 78/100

Tandem Diabetes Care Inc at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 09, 2021 / 05:10PM GMT
Release Date Price: €116.6 (+3.51%)
Matthew Stephan Miksic;dit Suisse AG
CrÃ;Research Division - Senior Research Analyst

© -

Well, listen, thanks, everybody, for joining us. We're very pleased to have with again Tandem Diabetes. John Sheridan, President and CEO; Leigh Vosseller, Executive Vice President and CFO. My name is Matt Miksic, I cover medical supplies and devices at Credit Suisse. And as I mentioned, we're pleased to be able to host you again this year. Thanks for coming.

John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director

Absolutely. Good to see you.

Matthew Stephan Miksic;dit Suisse AG
CrÃ;Research Division - Senior Research Analyst

© -

And so I thought it might be helpful to start with -- as some people may know. And I think if we look at the chart on the stock to see is that strangely, you had a very strong Q3. And -- but the stock has responded due to some comments that you made on the call. And so I'd say -- I'm imagining you're getting a fair amount of questions

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot